Agrawal D, Hauser P, McPherson F, Dong F, Garcia A, Pledger WJ (1996) Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol 16: 4327–4336 PubMedCAS Google Scholar
Aprelikova O. Xiong Y, Liu ET (1995) Both p 1 and p21 families of cyclin-dependent kinase ( CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J Biol Chem 270: 18195–18197 Google Scholar
Artuso M, Esteve A, Bresil H, Vuillaume M, Hall J (1995) The role of the Ataxia telangiectasia gene in the p53, WAFI/CIPI(p21)- and GADD45-mediated response to DNA damage produced by ionising radiation. Oncogene I1: 1427–1435 Google Scholar
Bae I, Fan S, Bhatia K, Kohn KW, Fornace AJ, O’Connor PM (1995) Relationships between GI arrest and stability of the p53 and p2lCipl/Wafl proteins following gamma-irradiation of human lymphoma cells. Cancer Res 55: 2387–2393 PubMedCAS Google Scholar
Barboule N, Mazars P, Baldin V, Vidal S, Jozan S, Martel P, Valette A (1995) Expression of p2I WAFT/ CIPI is heterogeneous and unrelated to proliferation index in human ovarian carcinoma. Intl Cancer 63: 611–615 ArticleCAS Google Scholar
Bates S, Vousden KH (1996) p53 in signalling checkpoint arrest or apoptosis. Curr Opin Genet Dev 6: 12–18 Google Scholar
Bhatia K, Fan S, Spangler G, Weintraub M, O’Connor PM, Judde JG, Magrath I (1995) A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt’s lymphoma. Cancer Res 55: 1431–1435 PubMedCAS Google Scholar
Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon G.1 (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552–557 CAS Google Scholar
Bullrich F, MacLachlan TK, Sang N, Druck T, Veronese ME, Allen SL, Chiorazzi N, Koff A, Heubner K, Croce CM, et al. (1995) Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kipl, to regions involved in human cancer. Cancer Res 55: 1199–1205 PubMedCAS Google Scholar
Chen IT, Akamatsu M, Smith ML, Lung FD, Duba D, Roller PP, Fornace AJ, O’Connor PM (1996a) Characterization of p2lCipl/Wafl peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene 12: 595–607 PubMedCAS Google Scholar
Chen J, Jackson PK, Kirschner MW, Dutta A (1995) Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374: 386–388 ArticlePubMedCAS Google Scholar
Chen J, Peters R, Saha P, Lee P, Theodoras A, Pagano M, Wagner G, Dutta A (1996b) A 39 amino acid fragment of the cell cycle regulator p2I is sufficient to bind PCNA and partially inhibit DNA replication in vivo. Nucleic Acids Res 24: 1727–1733 ArticlePubMedCAS Google Scholar
ChenJ, Saha P, Kornbluth S, Dynlacht B, Dutta A (1996e) Cyclin-binding motifs are essential for the function of p21kip1. Mol Cell Biol 19: 4673–4682 Google Scholar
Chen J, Willingham T, Shuford M, Nisen PD (1996d) Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor p27KIP1. J Clin Invest 97: 1983–1988 ArticlePubMedCAS Google Scholar
Coats S, Flanagan WM, Nourse J, Roberts JM (1996) Requirement of p27kip1 for restriction point control of the fibroblast cell cycle. Science 272: 877–880 ArticlePubMedCAS Google Scholar
Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21CIPI/WAFT undergo normal development, but are defective in GI checkpoint control. Cell 82: 675–684 ArticlePubMedCAS Google Scholar
Dulic V, Kaufmann WK, Wilson Si, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced GI arrest. Cell 76: 1013–1023 Google Scholar
EI-Deiry W, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAFT, a potential mediator of p53 tumor suppression. Cell 75: 817–825 Article Google Scholar
EI-Deiry W, Harper JW, O’Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, et al. (1994) WAFI/CIPI is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169–1174 Google Scholar
Ezhevsky SA, Toyoshima H, Hunter T, Scott DW (1996) Role of cyclin A and p27 in anti-IgM-induced GI growth arrest of murine B-cell lymphomas. Mol Biol Cell 7: 553–564 PubMedCAS Google Scholar
Fang F, Orend G, Watanabe N, Hunter T, Ruoslahti E (1996) Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271: 499–502 ArticlePubMedCAS Google Scholar
Fero ML, Rivkin M, Tasch M, Porter P. Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kipl)-deficient mice. Cell 85: 733–744 ArticlePubMedCAS Google Scholar
Ferrando AA, Balbin M, Pendas AM, Vizoso F, Velasco G, Lopez-Otin C (1995) Mutational analysis of the human cyclin-dependent kinase inhibitor p27K’rj in primary breast carcinomas. Hum Genet 967: 91–94 Google Scholar
Fotedar R, Fitzgerald P, Rousselle T, Cannella D, Doree M. Messier H, Fotedar A (1996) p2I contains independent binding sites for cyclin and cdk2:both sites are required to inhibit cdk2 kinase activity. Oncogene 12: 2155–2164 Google Scholar
Gao X, Chen YQ, Wu N. Grignon DJ, Sakr W, Porter AT, Honn KV (1995) Somatic mutations of the WAFI/CIPI gene in primary prostate cancer. Oncogene 11: 1395–1398 PubMedCAS Google Scholar
Goubin F, Ducommun B (1995) Identification of binding domains on the p2lCipl cyclin-dependent kinase inhibitor. Oncogene 10: 2281–2287 PubMedCAS Google Scholar
Gu Y, Turck CW, Morgan DO (1993) Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707–710 ArticlePubMedCAS Google Scholar
Gulbis JM, Kelman Z, Hurwitz J, O’Donnel M, Kuriyan, J (1996) Structure of the C-terminal region of p2lwar /Ci~~ complexed with human PCNA. Cell 87: 297–306 ArticlePubMedCAS Google Scholar
Guo K, Wang J, Andres V, Smith RC, Walsh K (1995) MyoD-induced expression of p21 inhibits cyclin- dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 15: 3823–3829 PubMedCAS Google Scholar
Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018–1021 ArticlePubMedCAS Google Scholar
Hall M, Bates S, Peters G (1995) Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11: 1581–1588 PubMedCAS Google Scholar
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge S J (1993) The p21 Cdk-interacting protein Cipl is a potent inhibitor of GI cyclin-dependent kinases. Cell 75: 805–816 ArticlePubMedCAS Google Scholar
Harper JW, Elledge SJ, Keyomarsi K et al. (1995) Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6: 387–400 PubMedCAS Google Scholar
Hatada I, Mukai T (1995) Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet 11: 204–206 ArticlePubMedCAS Google Scholar
Hengst L, Reed SI (1996) Translational control of p27Kipl accumulation during the cell cycle. Science 271: 1861–1864 ArticlePubMedCAS Google Scholar
Hengst L, Dulic V, Slingerland JM, Lees E, Reed SI (1994) A cell cycle-regulated inhibitor of cyclindependent kinases. Proc. Natl Acad Sci USA 91: 5291–5295 Google Scholar
Hirama T, Koefer HP (1996) Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 86: 841–854 Google Scholar
Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253: 49–53 Google Scholar
Kastan MB, Zhan Q, EI-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell 71: 587–597 ArticlePubMedCAS Google Scholar
Kato JY, Matsuoka M, Polyak K. Massague J, Sherr CJ (1994) Cyclic AMP-induced GI phase arrest mediated by an inhibitor (p27Kipl) of cyclin-dependent kinase 4 activation. Cell 79: 487–496 ArticlePubMedCAS Google Scholar
Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilcyznski S, et al. (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/ Kip1 in human malignancies. Cancer Res 55: 2266–2269 PubMedCAS Google Scholar
Kawamata N, Seriu T, Koeffler HP, Bartram CR (1996) Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTSI/INK4A), p18(INK4C) and p27(Kipl) genes in neuroblastomas. Cancer 77: 570–575 ArticlePubMedCAS Google Scholar
Kiwacki RW, Hengst L, Tennant L, Reed SI, Wright PE (1996) Structural studies of p21 Wafl/Cipl/Sdil in the free and Cdk2 bound state: conformational disorder mediates binding diversity. Proc Natl Acad Sci USA 93: 11504–11507 Article Google Scholar
Kiyokawa H, Kineman RD, Manova TK, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A (1996) Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85: 721–732 ArticlePubMedCAS Google Scholar
Kondo M, Matsuoka S. Uchida K, Osada H, Nagatake M, Takagi K, Harper JW, Takahashi T, Elledge SJ, Takahashi T (1996) Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. Oncogene 12: 1365–1368 CAS Google Scholar
Kranenburg O, Scharnhorst V, Van der Eb A, Zantema A (1995) Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J Cell Biol 131: 227–234 ArticlePubMedCAS Google Scholar
Lee MH, Reynisdottir I, Massague J (1995) Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9: 639–649 ArticlePubMedCAS Google Scholar
Lee MH, Nikolic M, Baptista CA, Lai E, Tsai LH, Massague J (1996) The brain-specific activator p35 allows CdkS to escape inhibition by p27Kip1 in neurons. Proc Natl Acad Sci USA 93: 3259–3263 ArticlePubMedCAS Google Scholar
Li R, Waga S, Hannon GJ, Beach D. Stillman B (1994) Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534–537 ArticlePubMedCAS Google Scholar
Li R, Hannon GJ, Beach D, Stillman B (1996) Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage. Curr Biol 6: 189–199 ArticlePubMedCAS Google Scholar
Liu M, Felling JC (1995) UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAFT/ CIP I expression. Oncogene 10: 1955–1960 PubMedCAS Google Scholar
Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10: 142–153 ArticlePubMedCAS Google Scholar
Luo Y, Hurwitz J, Massague J (1995) Cell-cycle inhibition by independent CDK and PCNA binding domains in p2lCipl. Nature 375: 159–161 ArticlePubMedCAS Google Scholar
Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9: 935–944 Google Scholar
Mal A, Poon R, Howe PH, Toyoshima H, Hunter T, Harter ML (1996) Inactivation of p27K’Pl by the viral EIA oncoprotein in TGF-(3 treated cells. Nature 380: 262–265 ArticlePubMedCAS Google Scholar
Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ (1995) p57KIP2, a structurally distinct member of the p21CIPl Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9: 650–662 Google Scholar
Matsuoka S, Thompson JS, Edwards MC, Barletta JM, Grundy P, Kalikin LM, Harper JW, Elledge Si, Feinberg AP (1996) Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57kip2, on chromosome 11p15. Proc Natl Acad Sci USA 93: 3026–3030 ArticlePubMedCAS Google Scholar
McDonald ER, Wu GS, Waldman T, El Deiry WS (1996) Repair defect in p21 WAFI/CIPI-/- human cancer cells. Cancer Res 56: 2250–2255 PubMedCAS Google Scholar
Medrano EE, Im S, Yang F, Abdel MZ (1995) Ultraviolet B light induces GI arrest in human melanocytes by prolonged inhibition of retinoblastoma protein phosphorylation associated with long-term expression of the p21Waf-1/SDI-I/Cip-1 protein. Cancer Res 55: 4047–4052 PubMedCAS Google Scholar
Nakanishi M, Robetorye RS, Adami GR, Pereira SO, Smith JR (1995a) Identification of the active region of the DNA synthesis inhibitory gene p2lSdil/CIPI/WAFI. Embo J 14: 555–563 PubMedCAS Google Scholar
Nakanishi M, Robetorye RS, Pereira SO, Smith JR (1995b) The C-terminal region of p21SD11/WAF1/ CIPI is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition. J Biol Chem 270: 17060–17063 ArticlePubMedCAS Google Scholar
Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K (1996) Mice lacking p27(Kipl) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707–720 ArticlePubMedCAS Google Scholar
Noda A, Ning Y, Venable SF, Pereira SO, Smith.JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211: 90–98 ArticlePubMedCAS Google Scholar
Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GR, Roberts JM (1994) Interleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570–573 ArticlePubMedCAS Google Scholar
Orlow I, Iavarone A, Crider-Miller SJ, Bonilla F, Latres E, Lee M-H, Gerald WL, Massague J, Weissman BE, Cordon-Cardo C (1996) Cyclin-dependent kinase inhibitor, p57Kip2 in soft tissue sarcomas and Wilm’s tumors. Cancer Res 56: 1219–1221 PubMedCAS Google Scholar
Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682–685 ArticlePubMedCAS Google Scholar
Pan ZQ, Reardon JT, Li L, Flores RH, Legerski R, Sancar A, Hurwitz J (1995) Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. J Biol Chem 270: 22008–22016 ArticlePubMedCAS Google Scholar
Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ (1995) p53-independent expression of p2lCipl in muscle and other terminally differentiating cells. Science 267: 1024–1027 Google Scholar
Petrocelli T, Poon R, Drucker DJ, Slingerland JM, Rosen CF (1996) UVB radiation induces p2lCipl/ WAFT and mediates GI and S phase checkpoints. Oncogene 12: 1387–1396 PubMedCAS Google Scholar
Pietenpol JA, Bohlander SK, Sato Y, Papadopoulos N, Liu B, Friedman C, Trask BJ, Roberts JM, Kinzler KW, Rowley JD et al. (1995) Assignment of the human p27Kipl gene to 12p13 and its analysis in leukemias. Cancer Res 55: 1206–1210 PubMedCAS Google Scholar
Podust VN, Podust LM, Goubin F, Ducommun B, Hubscher U (1995) Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry 34: 8869–8875 ArticlePubMedCAS Google Scholar
Pollock PM, Pearson JV, Hayward NK (1996) Compilation of somatic mutations of the CDKN2 gene in human cancers:non-random distribution of base substitutions. Genes Chrom Cancer 15: 77–88 ArticlePubMedCAS Google Scholar
Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A (1994a) p27Kipl, a cyclinCdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8: 9–22 Google Scholar
Polyak K, Lee MH, Erdjument BH, Koff A, Roberts JM, Tempst P, Massague J (1994b) Cloning of p27Kipl. a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59–66 ArticlePubMedCAS Google Scholar
Ponce CM, Lee MH, Latres E, Polyak K, Lacombe L, Montgomery K, Mathew S, Krauter K, Sheinfeld J, Massague J, Cordon-Cardo C (1995) p27Kipl: chromosomal mapping to 12p12–12p13.1 and absence of mutations in human tumors. Cancer Res 55: 1211–1214 Google Scholar
Poon RY, Toyoshima H, Hunter T (1995) Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol Biol Cell 6: 1197–1213 PubMedCAS Google Scholar
Reid LH, Crider-Miller SJ, West A, Lee M.-H, Massague J, Weissman BE (1996) Genomic organization of human p57Kip2 gene and its analysis in the G401 Wilm’s tumor assay. Cancer Res 56: 1214–1218 PubMedCAS Google Scholar
Resnitzky D, Hengst L, Reed SI (1995) Cyclin A-associated kinase complex activity is rate limiting for entrance into S phase and is negatively regulated in GI by p27K’°. Mol Cell Biol 15: 4347–4352 PubMedCAS Google Scholar
Reynisdottir I, Polyak K, Iavarone A, Massague J (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 9: 1831–1845 ArticlePubMedCAS Google Scholar
Russo AA, Jeffrey PD, Patten AK, Massague J, Pavletich NP (1996) Crystal structure of the p27 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382: 325–331 ArticlePubMedCAS Google Scholar
Schulze A, Zerfass-Thome K, Berges J, Middendorf S, Jansen-Duerr P, Henglein B (1996) Anchorage-dependent transcription of the cyclin A gene. Mol Cell Biology 16: 4632–4638 CAS Google Scholar
Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D, DePinho RA (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27–37 ArticlePubMedCAS Google Scholar
Shivji MK, Grey SJ, Strausfeld UP, Wood RD, Blow JJ (1994) Cipl inhibits DNA replication but not PCNA-dependent nucleotide excision-repair. Current Biology 4: 1062–1068 ArticlePubMedCAS Google Scholar
Shou W, Dunphy WG (1996) Cell cycle control by Xenopus p28kipa developmentally regulated inhibitor of cyclin dependent kinases. Mol Biol Cell 7: 457–469 PubMedCAS Google Scholar
Skapek SX, Rhee J, Spicer DB, Lassar AB (1995) Inhibition of myogenic differentiation in proliferating myoblasts by cyclin DI-dependent kinase. Science 267: 1022–1024 ArticlePubMedCAS Google Scholar
Slingerland JM, Hengst L, Pan CH, Alexander D, Stampfer MR, Reed SI (1994) A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol 14: 3683–3694 PubMedCAS Google Scholar
Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A (1996) Formation of p27-Cdk complexes during the human mitotic cell cycle. Cell Growth Diff 7: 135–146 PubMedCAS Google Scholar
Su JY, Rempel RE, Erikson E, Mailer JL (1995) Cloning and characterization of the Xenopus cyclindependent kinase inhibitor p27kip1. Proc Natl Acad Sci USA 92: 10187–10191 ArticlePubMedCAS Google Scholar
Sun Y, Hildesheim A, Li H, Li Y, Chen JY, Cheng YI, Hayes RB, Rothman N, Bi WF, Cao Y et al. (1995) No point mutation but a codon 31serarg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese. Cancer Epidemiol Biomarkers Prey 4: 261–267 CAS Google Scholar
Takeuchi S, Mori N, Koike M, Slater J, Park S, Miller CW, Miyoshi I, Koeffler, HP (1996) Frequent loss of heterozygosity in region of the KIPI locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. Cancer Res 56: 738–740 PubMedCAS Google Scholar
Toyoshima H, Hunter T (1994) p27, a novel inhibitor of GI cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67–74 Google Scholar
Vidal MJ, Loganzo FJ, de Oliveira AR, Hayward NK, Albino AP (1995) Mutations and defective expression of the WAFT p21 tumour-suppressor gene in malignant melanomas. Melanoma Res 5: 243–250 CAS Google Scholar
Waga S, Hannon GJ, Beach D, Stillman B (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574–578 ArticlePubMedCAS Google Scholar
Waldman T, Kinzler KW, Vogelstein B (1995) p21 is necessary for the p53-mediated GI arrest in human cancer cells. Cancer Res 55: 5187–5190 Google Scholar
Wang QM, Jones JB, Studzinski GP (1996) Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res 56: 264–267 PubMedCAS Google Scholar
Warbrick E. Lane DP, Glover DM, Cox LS (1995) A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21 WAFI and proliferating cell nuclear antigen. Curr Biol 5: 275–282 ArticlePubMedCAS Google Scholar
Watanabe H, Fukuchi K, Takagi Y, Tomoyasu S, Tsuruoka N, Gomi K (1995) Molecular analysis of the Cipl/Waft (p21) gene in diverse types of human tumors. Biochim Biophys Acta 1263: 275–280 PubMed Google Scholar
Winston J, Dong F, Pledger WJ (1996) Differential modulation of GI cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J Biol Cheri 271: 11253–11260 ArticleCAS Google Scholar
Xiong Y, Zhang H, Beach D (1992) D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71: 505–514 ArticlePubMedCAS Google Scholar
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993a) p21 is a universal inhibitor of cyclin kinases. Nature 366: 701–704 Google Scholar
Xiong Y, Zhang H, Beach D (1993b) Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7: 1572–1583 ArticlePubMedCAS Google Scholar
Zhang H, Xiong Y, Beach, D. (1993) Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 4: 897–906 PubMedCAS Google Scholar
Zhang H, Hannon GJ, Beach D (1994a) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8: 1750–1758 ArticlePubMedCAS Google Scholar
Zhang H, Hannon GJ, Casso D, Beach D (1994b) p21 is a component of active cell cycle kinases. Cold Spring Harb Symp Quant Biol 59: 21–29 PubMedCAS Google Scholar
Zhu X, Ohtsubo M, Bohmer RM, Roberts JM, Assoian RK (1996) Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol 133: 391–403 ArticlePubMedCAS Google Scholar